Celltrion
068270.KS
#657
Rank
S$40.62 B
Marketcap
$196.12
Share price
0.00%
Change (1 day)
31.18%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Market capitalization of Celltrion (068270.KS)

Market cap: S$40.62 Billion

As of September 2024 Celltrion has a market cap of S$40.62 Billion. This makes Celltrion the world's 657th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Celltrion from 2007 to 2024

End of year Market Cap

Year Market cap Change
2024S$40.62 B-8.14%
2023S$44.21 B81.93%
2022S$24.30 B-22.27%
2021S$31.27 B-47.54%
2020S$59.61 B122.64%
2019S$26.77 B-20.86%
2018S$33.83 B-1.73%
2017S$34.42 B118.81%
2016S$15.73 B37.5%
2015S$11.44 B139.13%
2014S$4.78 B5.86%
2013S$4.52 B-14.99%
2012S$5.31 B12.45%
2011S$4.72 B6.44%
2010S$4.44 B139.72%
2009S$1.85 B59.79%
2008S$1.15 B4193.7%
2007S$27.01 M

End of Day market cap according to different sources

On Sep 20th, 2024 the market cap of Celltrion was reported to be:

S$40.62 Billion
by Yahoo Finance info icon info icon
S$40.62 Billion
by CompaniesMarketCap info icon info icon